Skip to main content
BerGenBio logo

BerGenBio — Investor Relations & Filings

Ticker · BGBIO ISIN · NO0013711713 LEI · 213800TYYFXKYF3V2A23 OL Manufacturing
Filings indexed 961 across all filing types
Latest filing 2025-10-29 M&A Activity
Country NO Norway
Listing OL BGBIO

About BerGenBio

https://www.bergenbio.com/

BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.

Recent filings

Filing Released Lang Actions
Merger of BerGenBio and Oncoinvent completed
M&A Activity Classification · 100% confidence The document announces the formal completion of a statutory triangular merger between BerGenBio ASA and Oncoinvent ASA. It details the registration of the merger, the dissolution of one entity, the name change of the combined company, and the issuance of merger consideration shares. Since the document focuses on the finalization of a merger transaction, it falls under M&A Activity.
2025-10-29 English
BerGenBio and Oncoinvent - Last day of trading in the shares of Oncoinvent
Delisting Announcement Classification · 100% confidence The document is a short announcement regarding the final day of trading for Oncoinvent shares due to a merger with BerGenBio. While it relates to a merger (M&A), the specific content focuses on the cessation of trading on the exchange, which is a direct consequence of the merger completion. Given the document's focus on the trading status of the shares, it fits the M&A activity category (TAR) as it pertains to the finalization of a merger transaction.
2025-10-29 English
BerGenBio ASA: Approval and publication of prospectus
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the approval and publication of a prospectus for a merger and a rights issue. It explicitly states that it is an advertisement and not the prospectus itself, and provides links to where the actual prospectus can be found. Following the 'Menu vs Meal' rule, this is an announcement of a report/document rather than the document itself, fitting the criteria for a Report Publication Announcement (RPA).
2025-10-28 English
BerGenBio and Oncoinvent - Key Dates for Completion of Merger
M&A Activity Classification · 100% confidence The document is an official announcement regarding the completion of a merger between BerGenBio ASA and Oncoinvent ASA. It details the timeline, share exchange ratios, ticker changes, and capital structure adjustments resulting from the merger. Since this document describes the execution and specific terms of a merger transaction, it falls under the M&A Activity category.
2025-10-24 English
BerGenBio ASA: Updated Key Information related to the contemplated Rights Issue
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from BerGenBio ASA regarding a 'Rights Issue' (a capital raising event) and a 'Merger'. It provides specific details such as the subscription price calculation, ex-date, record date, and subscription ratio. While it mentions a merger, the primary focus is on the capital structure change and the mechanics of the rights issue. This fits the definition of a 'Share Issue/Capital Change' (SHA) as it details the issuance of new shares and the associated capital structure adjustments.
2025-09-17 English
BerGenBio ASA: Updated information regarding the contemplated Rights Issue and Merger
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding updates to a previously announced merger and rights issue. It details changes to the timeline for the prospectus approval, merger completion, and subscription period. Since it concerns a merger proposal and related financing activities, it falls under M&A activity (TAR).
2025-09-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.